{"name":"SK Chemicals Co., Ltd.","slug":"sk-chemicals-co-ltd","ticker":"","exchange":"","domain":"skchemicals.com","description":"","hq":"Seongnam","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":9,"colorKey":"immunology","drugs":[{"name":"NBP607","genericName":"NBP607","slug":"nbp607","indication":"Other","status":"phase_3"},{"name":"NBP608","genericName":"NBP608","slug":"nbp608","indication":"Other","status":"phase_3"},{"name":"Agrippal S1","genericName":"Agrippal S1","slug":"agrippal-s1","indication":"Seasonal influenza prevention in adults and children","status":"phase_3"},{"name":"GNX80","genericName":"GNX80","slug":"gnx80","indication":"Other","status":"marketed"},{"name":"NBP607-QIV","genericName":"NBP607-QIV","slug":"nbp607-qiv","indication":"Seasonal influenza prevention in adults and/or pediatric populations","status":"phase_3"},{"name":"NBP607-TIV","genericName":"NBP607-TIV","slug":"nbp607-tiv","indication":"Influenza treatment and prevention","status":"phase_3"},{"name":"NBP607-Y","genericName":"NBP607-Y","slug":"nbp607-y","indication":"Tissue regeneration and repair (specific indication under investigation in Phase 3)","status":"phase_3"},{"name":"Ongentys 50mg","genericName":"Ongentys 50mg","slug":"ongentys-50mg","indication":"Other","status":"marketed"},{"name":"Placebo(For THVD-201)","genericName":"Placebo(For THVD-201)","slug":"placebo-for-thvd-201","indication":"Control arm in THVD-201 clinical trial (indication unknown)","status":"phase_3"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"cardiovascular","drugs":[{"name":"Prodiax-23","genericName":"Prodiax-23","slug":"prodiax-23","indication":"Phase 3 clinical trials for metastatic non-small cell lung cancer","status":"phase_3"},{"name":"SK-PC-B70M","genericName":"SK-PC-B70M","slug":"sk-pc-b70m","indication":"Melanoma (in combination with checkpoint inhibitors)","status":"phase_3"},{"name":"SID530, Taxotere","genericName":"SID530, Taxotere","slug":"sid530-taxotere","indication":"Adjuvant treatment of node-positive breast cancer","status":"phase_3"},{"name":"THVD-201","genericName":"THVD-201","slug":"thvd-201","indication":"HPV-positive cervical cancer","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"neuroscience","drugs":[{"name":"SID142","genericName":"SID142","slug":"sid142","indication":"Type 2 diabetes","status":"phase_3"},{"name":"SKCPT","genericName":"SKCPT","slug":"skcpt","indication":"Type 2 diabetes","status":"phase_3"},{"name":"NBP606","genericName":"NBP606","slug":"nbp606","indication":"Type 2 diabetes","status":"phase_3"},{"name":"NBP607-V","genericName":"NBP607-V","slug":"nbp607-v","indication":"Type 2 diabetes mellitus","status":"phase_3"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Hepabulin IV","genericName":"Hepabulin IV","slug":"hepabulin-iv","indication":"Thromboembolism prevention and treatment","status":"phase_3"},{"name":"Rinexin® Tab","genericName":"Rinexin® Tab","slug":"rinexin-tab","indication":"Hypertension","status":"phase_3"},{"name":"S-amlodipine gentisate","genericName":"S-amlodipine gentisate","slug":"s-amlodipine-gentisate","indication":"Hypertension","status":"phase_3"}]}],"pipeline":[{"name":"Hepabulin IV","genericName":"Hepabulin IV","slug":"hepabulin-iv","phase":"phase_3","mechanism":"Hepabulin IV is a human serum albumin-based therapeutic that delivers heparin conjugate to provide anticoagulant and anti-inflammatory effects.","indications":["Thromboembolism prevention and treatment","Disseminated intravascular coagulation (DIC)"],"catalyst":""},{"name":"NBP607","genericName":"NBP607","slug":"nbp607","phase":"phase_3","mechanism":"NBP607 is a novel therapeutic agent in development by SK Chemicals, currently in phase 3 clinical trials.","indications":[],"catalyst":""},{"name":"NBP608","genericName":"NBP608","slug":"nbp608","phase":"phase_3","mechanism":"NBP608 is a novel therapeutic agent in development by SK Chemicals, currently in phase 3 clinical trials.","indications":[],"catalyst":""},{"name":"Prodiax-23","genericName":"Prodiax-23","slug":"prodiax-23","phase":"phase_3","mechanism":"Prodiax-23 is a small molecule that targets the PI3K/AKT pathway.","indications":["Phase 3 clinical trials for metastatic non-small cell lung cancer"],"catalyst":""},{"name":"SID142","genericName":"SID142","slug":"sid142","phase":"phase_3","mechanism":"SID142 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"SK-PC-B70M","genericName":"SK-PC-B70M","slug":"sk-pc-b70m","phase":"phase_3","mechanism":"SK-PC-B70M is a therapeutic cancer vaccine designed to stimulate immune responses against tumor-associated antigens.","indications":["Melanoma (in combination with checkpoint inhibitors)","Non-small cell lung cancer (in combination with checkpoint inhibitors)"],"catalyst":""},{"name":"SKCPT","genericName":"SKCPT","slug":"skcpt","phase":"phase_3","mechanism":"SKCPT is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"Agrippal S1","genericName":"Agrippal S1","slug":"agrippal-s1","phase":"phase_3","mechanism":"Agrippal S1 is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against seasonal influenza virus strains.","indications":["Seasonal influenza prevention in adults and children"],"catalyst":""},{"name":"GNX80","genericName":"GNX80","slug":"gnx80","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"NBP606","genericName":"NBP606","slug":"nbp606","phase":"phase_3","mechanism":"NBP606 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"NBP607-QIV","genericName":"NBP607-QIV","slug":"nbp607-qiv","phase":"phase_3","mechanism":"NBP607-QIV is a quadrivalent influenza vaccine designed to provide immunological protection against four strains of influenza virus.","indications":["Seasonal influenza prevention in adults and/or pediatric populations"],"catalyst":""},{"name":"NBP607-TIV","genericName":"NBP607-TIV","slug":"nbp607-tiv","phase":"phase_3","mechanism":"NBP607-TIV is a therapeutic influenza vaccine designed to enhance immune response against multiple influenza virus strains.","indications":["Influenza treatment and prevention"],"catalyst":""},{"name":"NBP607-V","genericName":"NBP607-V","slug":"nbp607-v","phase":"phase_3","mechanism":"NBP607-V is a recombinant human albumin-fused glucagon-like peptide-1 (GLP-1) receptor agonist that enhances insulin secretion and reduces glucagon levels to improve glycemic control.","indications":["Type 2 diabetes mellitus"],"catalyst":""},{"name":"NBP607-Y","genericName":"NBP607-Y","slug":"nbp607-y","phase":"phase_3","mechanism":"NBP607-Y is a dual-acting agent that modulates immune function and promotes tissue regeneration through a novel mechanism.","indications":["Tissue regeneration and repair (specific indication under investigation in Phase 3)"],"catalyst":""},{"name":"Ongentys 50mg","genericName":"Ongentys 50mg","slug":"ongentys-50mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Placebo(For THVD-201)","genericName":"Placebo(For THVD-201)","slug":"placebo-for-thvd-201","phase":"phase_3","mechanism":"Placebo is an inert substance with no active pharmacological mechanism.","indications":["Control arm in THVD-201 clinical trial (indication unknown)"],"catalyst":""},{"name":"Rinexin® Tab","genericName":"Rinexin® Tab","slug":"rinexin-tab","phase":"phase_3","mechanism":"Rinexin is a small molecule that inhibits the renin-angiotensin system.","indications":["Hypertension"],"catalyst":""},{"name":"S-amlodipine gentisate","genericName":"S-amlodipine gentisate","slug":"s-amlodipine-gentisate","phase":"phase_3","mechanism":"S-amlodipine gentisate is a calcium channel blocker that relaxes blood vessels and reduces blood pressure by blocking L-type calcium channels in vascular smooth muscle.","indications":["Hypertension"],"catalyst":""},{"name":"SID530, Taxotere","genericName":"SID530, Taxotere","slug":"sid530-taxotere","phase":"phase_3","mechanism":"Taxotere works by inhibiting microtubule formation in the mitotic spindle, resulting in cell cycle arrest at the G2/M phase and apoptosis.","indications":["Adjuvant treatment of node-positive breast cancer","Locally advanced or metastatic breast cancer","Non-small cell lung cancer","Prostate cancer"],"catalyst":""},{"name":"THVD-201","genericName":"THVD-201","slug":"thvd-201","phase":"phase_3","mechanism":"THVD-201 is a therapeutic vaccine designed to stimulate immune responses against human papillomavirus (HPV) for the treatment of HPV-related cancers.","indications":["HPV-positive cervical cancer","HPV-positive head and neck cancer"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNZUJtZE9zVk15Y3Vab2x3N2ZBdWppZEU1Tk81LXBRNk94N1RONVN3aEI3UmVxNF9SSDJxMjBTdkFtUmtWX3F4VjVwRXBnVmsySGl1Y3hEUDVVZ0FEa05rbkdYLXlxd3RaNk9YcGtEcTc3RE42WlJPbWhkREJETURqdUdvN3J6bmk2RnNkdjVUalVicmh5U3Iw?oc=5","date":"2026-03-26","type":"deal","source":"BioWorld News","summary":"Korea roundup: Alteogen, Celltrion lead biotech deals - BioWorld News","headline":"Korea roundup: Alteogen, Celltrion lead biotech deals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQM1ljc3BHcmppNWszd0YtQ2M1TmFnaW14UmJrWGtpdTg4eHpOUDhuR0dzYnJRNWUxeDlIMTFjY0RiUDJtVWJMNVZHejN6TXc5UWxROWRnRlpEOWQzMzVRd20xTGZwbGZDRUVWYW1mLUo3aFVab2Q4bUIyeXF3SVJGdXctWkpZY3hMM2pOOFdPa0lCaG5uZURRZlZMS3l6dw?oc=5","date":"2026-01-22","type":"pipeline","source":"DCAT Value Chain Insights","summary":"Industry Roundtable: Small-Molecule APIs: What’s in Store for 2026? - DCAT Value Chain Insights","headline":"Industry Roundtable: Small-Molecule APIs: What’s in Store for 2026?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1pNm1OcDZuQVlUUG5yb0RQLXB1cVU5WGlpbmdmWW92bkxsY1A5NFhoYmJXczhaZ3hOZnpxZVVDc0Yzdm9RUy1LNnFiU0FMQW1yc2lMb1FSZnFMMHpTSDN4TVUzOUJ6VElvVzVkY0130gFyQVVfeXFMTUZKeXNRTHlpd3pQelFIUDJOeElPdkN4YlJnbl8wTGNnUk5acE5VZzR3WnNqUDdhcVhVdF9LaEI1Y3c5MGZxRTh2aWV6WXVTRDVYZ0Z3aXpSUFRoTU11WE15aWFjWVZxQmNaWHRtYkJDeXRB?oc=5","date":"2025-12-26","type":"pipeline","source":"koreabiomed.com","summary":"SK chemicals signs R&D pact with Nextgen Biosciences to expand early drug pipeline - koreabiomed.com","headline":"SK chemicals signs R&D pact with Nextgen Biosciences to expand early drug pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE9fZGRyZjFMZFhpbDdhSkJLV00yVy1oZ3RrM245T1NkcGFucFpGZktadFp6UW5tWjh5SnVfbEd3TTJMSnhKcGNIc0tEZy1RQXliLXMwNUxrMA?oc=5","date":"2025-12-26","type":"pipeline","source":"The Korea Herald","summary":"SK Chemicals bolsters new drug development through open innovation - The Korea Herald","headline":"SK Chemicals bolsters new drug development through open innovation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiQkFVX3lxTFBvaHhLTnpzcGZhejc3STJqVzBscHRxZ0RvMFMwNFRJamt4V0Q4N1NhMVNGcS1jdENlT01jekdqNnhFZw?oc=5","date":"2025-06-10","type":"deal","source":"코메디닷컴","summary":"AriBio Signs Alzheimer’s Drug Licensing Deal Worth $600 Million with UAE Pharma Company - 코메디닷컴","headline":"AriBio Signs Alzheimer’s Drug Licensing Deal Worth $600 Million with UAE Pharma Company - 코메디닷컴","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxPSnltY0tadUhUWU0wTkgzQmY5YjAwMTVOXzNxd0F3ZWNvQ0hYMEdweUUyeTNKMkI1ckdfbmdVYkFud2JCbDllWVpuZjN0dFYtQWVZZHZMSDdkekZyYU5HZTk0M3RYYTJyT0t0OWh0WGF0X3lsamhod3RXemh3MDl3QW90REE5WWJMejUxSVcxVXhDT1F0NGE4Q1JtbG5maDA1R0xjNWF1Y3ViM0NaWkwwMmgwN1lYR3BMRVBjTTFYdVZpYnZCSEVJajBEZGh2UWJPQ1E?oc=5","date":"2025-03-06","type":"pipeline","source":"BioSpectrum Asia","summary":"SK Chemicals inks agreement with Viatris to expand pain management portfolio in Korea - BioSpectrum Asia","headline":"SK Chemicals inks agreement with Viatris to expand pain management portfolio in Korea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE9QWTNBTzlXSHI5d0J0N1BQMXBwejNxN3lCTFNHWXFLeF9MNkRaeVI3UnRLWEM1NnZYZFI0Rm9zNGZYTTc4S1EwWWRpWHdkV2ZTZi1pS1RFMA?oc=5","date":"2023-09-22","type":"pipeline","source":"매일경제","summary":"SK chemicals to sell pharmaceutical business to Glenwood PE - 매일경제","headline":"SK chemicals to sell pharmaceutical business to Glenwood PE - 매일경제","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE9hSWVfdWpBM1dmcW9WOTFYYnFaUEQ1ZWZkVC14VWRVbk5NWHQ4amlBbzhNM0hjUjBDMFJZeWxoMXgtU0RKVEVTQk8ySXl6UFBXVDlXYmZxM0taYjBSTW1oaDFsV2ZvSlBzMTlfU24xUXJvcHBNWE82UHNkNA?oc=5","date":"2023-09-21","type":"pipeline","source":"KED Global","summary":"SK Chemicals to sell pharmaceutical unit to Glenwood PE - KED Global","headline":"SK Chemicals to sell pharmaceutical unit to Glenwood PE","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOV3J4VUF1RG5jUUdZUE9OYUZLM3F2QkJzQnkyeGQxZzZkbHFNRjQ5SE1ZcF94azItOTduSGVFWFNDeXo2T1NmcHhURDhLUEJVSmR6enJxRm1LVFJ4TkxQRUtxQ0lQUjRpVmlWWlItN2o1a0JTdkRsOGIwMmplckJVV2NaaGJRdUF0NzMtZlVHVXRLNlNWQU91dWtaX1A5My0ydEo0?oc=5","date":"2023-07-24","type":"pipeline","source":"Fierce Pharma","summary":"AstraZeneca enlists SK Chemicals to produce diabetes combo drug Sidapvia - Fierce Pharma","headline":"AstraZeneca enlists SK Chemicals to produce diabetes combo drug Sidapvia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFB1cG9mWGlHeVd1QjhmelRuLWVzSHZ6ODRBZExseHpmSUtXTnhHNEt2UGpRdzVETUdFU3pNR2pyNFEydVhXZDFZYVNWZzNiQzdPYmU5ZVlLWHJkNTlSWnZkbjBMMXM5M0hJa2VzNy13?oc=5","date":"2023-06-19","type":"pipeline","source":"KED Global","summary":"SK Chemicals, AZ mark first commercial production of diabetes drugs - KED Global","headline":"SK Chemicals, AZ mark first commercial production of diabetes drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxNQk4xLXBJVF95N0JlN2dCRlNpaFhYblZHdGVfREtUOVhPUzNadWpyalNJSkRkcGNWS25yOC1LMGNnbnU3Q2tyZDZKaEthMnRUdFkzM2c2d1RoNkFaY1R0Ui1Ja1FpbDlvbFdoNld5Q21maGM3MEJrbHlQOWZaVjI1WnZVN2RBalNGVzJxXzlQLXZJWlhMYmlxdDlaQllMUEt6VlB2TDEyc3VBakVFYUtMalZXbVRjTGZ4OHR1Vzg2OXZSa0ZtX0JXMlZ5MjcwdlBQVHlPNW03VkgyRVBlS0FLQQ?oc=5","date":"2022-12-13","type":"pipeline","source":"prnewswire.com","summary":"Cyclica and SK Chemicals announce agreement to co-develop novel therapeutics - prnewswire.com","headline":"Cyclica and SK Chemicals announce agreement to co-develop novel therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNNG9VMDJNMVZjMjZKMF94RWE5Y2pFSUhkdlVtT0NFU09abF8tQV9seWRwWnk1ZTlRdHVrTGpIeE0zWTlvd2VxemxZRGw2SlB1TzZpMmZzd1laTGMtTXhpVThYWWp4aGpTckcxUXU1eHlHTGhBWlA2R0t0Q2U3OEhPZlRlQ1dteUhSeXZxbGVvd0ZxeWtFWm9KYWVXc095WmVIX2t0V0JqMGJNTFNBZlJ2Szk5ejg1bUU?oc=5","date":"2021-11-08","type":"pipeline","source":"BioSpace","summary":"Standigm Established a Synthetic Research Center to Improve Efficiency of AI Drug Discovery - BioSpace","headline":"Standigm Established a Synthetic Research Center to Improve Efficiency of AI Drug Discovery","sentiment":"neutral"}],"patents":[],"drugCount":20,"phaseCounts":{"phase_3":18,"marketed":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}